ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 143 filers reported holding ENDOCYTE INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $387,417 | -99.9% | 21,814 | 0.0% | 0.01% | +40.0% |
| Q2 2018 | $301,034,000 | +224552.2% | 21,814 | -25.7% | 0.01% | +400.0% |
| Q3 2015 | $134,000 | -36.2% | 29,340 | -12.4% | 0.00% | -50.0% |
| Q1 2015 | $210,000 | 0.0% | 33,505 | +0.5% | 0.00% | +100.0% |
| Q4 2014 | $210,000 | +3.4% | 33,337 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $203,000 | -7.7% | 33,337 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $220,000 | -64.7% | 33,337 | +27.2% | 0.00% | -50.0% |
| Q1 2014 | $624,000 | +122.9% | 26,208 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $280,000 | -19.8% | 26,208 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $349,000 | +1.5% | 26,208 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $344,000 | – | 26,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |